Novel Coronavirus Diagnosis and Detection Kits Market

Novel Coronavirus Diagnosis and Detection Kits Market contains market size and forecasts of Novel Coronavirus Diagnosis and Detection Kits in global, including the following market information:

• Global Novel Coronavirus Diagnosis and Detection Kits Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Novel Coronavirus Diagnosis and Detection Kits Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Novel Coronavirus Diagnosis and Detection Kits companies in 2021 (%)

The global Novel Coronavirus Diagnosis and Detection Kits market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Pharyngeal Swab Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Novel Coronavirus Diagnosis and Detection Kits include Shanghai GeneoDX Biotech Co., Ltd, Luoyang Ascend Biotechnology Co., Ltd, Maccura Biotechnology Co., Ltd., Shanghai Huirui Biotechnology Co.,Ltd., BioGerm, Liferiver, BGI, KHB and DAAN GENE, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Novel Coronavirus Diagnosis and Detection Kits manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Novel Coronavirus Diagnosis and Detection Kits Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Novel Coronavirus Diagnosis and Detection Kits Market Segment Percentages, by Type, 2021 (%)

• Pharyngeal Swab
• Nasal Swab
• Other

Global Novel Coronavirus Diagnosis and Detection Kits Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Novel Coronavirus Diagnosis and Detection Kits Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Other

Global Novel Coronavirus Diagnosis and Detection Kits Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Novel Coronavirus Diagnosis and Detection Kits Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Novel Coronavirus Diagnosis and Detection Kits revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Novel Coronavirus Diagnosis and Detection Kits revenues share in global market, 2021 (%)
• Key companies Novel Coronavirus Diagnosis and Detection Kits sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Novel Coronavirus Diagnosis and Detection Kits sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Shanghai GeneoDX Biotech Co., Ltd
• Luoyang Ascend Biotechnology Co., Ltd
• Maccura Biotechnology Co., Ltd.
• Shanghai Huirui Biotechnology Co.,Ltd.
• BioGerm
• Liferiver
• BGI
• KHB
• DAAN GENE
• Abbott Diagnostics.
• Accelerate Diagnostics
• Ador Diagnostics
• Akkoni Biosystems
• Alveo Technologies
• Applied BioCode
• Aus Diagnostics.
• BD Diagnostics
• Biocartis
• BioFire Diagnostics
• Saw Diagnostics
• Seegene
• Sensovation